使用白蛋白结合探针的分子3-T心脏磁共振成像在体内检测易损冠状动脉斑块的新方法
本研究纳入25例急性冠脉综合征或稳定性冠心病症状患者,在24小时内行钆磷维塞三钠增强心脏磁共振、临床指征的X线冠状动脉造影和光学相干断层扫描。钆磷维塞三钠给药约24小时后行GE-CMR,207个冠状动脉节段中罪犯病变节段信号增强显著高于无罪犯病变节段,检出罪犯病变敏感度82%、特异度83%,薄纤维帽粥样斑块节段信号也显著增高。作者首次在体内实现GE-CMR无创检测罪犯冠状动脉病变和薄纤维帽粥样斑块,认为该方法可能代表无创心血管风险预测的新途径。
要点
- 罪犯病变节段钆磷维塞增强后CNR为6.1(3.9–16.5),显著高于无罪犯病变节段的2.1(0.5–3.5),p<0.001。
- GE-CMR检出罪犯冠状动脉病变的敏感度为82%(9/11),特异度为83%(162/195)。
- OCT所示薄纤维帽粥样斑块节段CNR为9.2(3.3–13.7),显著高于无斑块或早期动脉粥样硬化病变节段的2.1(0.5–3.4),p=0.001。
核心结论
- 本研究首次在体内证明,使用钆磷维塞三钠增强心脏磁共振可无创检测冠状动脉罪犯病变和薄纤维帽粥样斑块。
- 作者认为该方法可能代表一种无创心血管风险预测的新途径。
研究设计与样本
- 研究纳入25例急性冠脉综合征或稳定性冠心病症状患者,均接受临床指征的X线冠状动脉造影和光学相干断层扫描,并在24小时内完成GE-CMR。
- GE-CMR在单次给予钆磷维塞三钠约24小时后进行,以血池信号为参照量化冠状动脉节段内的对比噪声比(CNR)。
- 共分析207个冠状动脉节段,其中急性冠脉综合征患者的罪犯病变节段11个、无罪犯病变节段196个;OCT所示薄纤维帽粥样斑块节段22个、无斑块或早期动脉粥样硬化病变节段185个。
关键影像表现/征象
- 急性冠脉综合征患者含罪犯病变的节段在钆磷维塞三钠给药后信号增强(CNR)显著高于无罪犯病变节段,分别为6.1(3.9–16.5)与2.1(0.5–3.5),p<0.001。
- OCT所示的薄纤维帽粥样斑块节段CNR显著高于无冠状动脉斑块或含早期动脉粥样硬化病变的节段,分别为9.2(3.3–13.7)与2.1(0.5–3.4),p=0.001。
诊断标准与关键数值
- 以XCA和OCT为参考,GE-CMR检出罪犯冠状动脉病变的敏感度为82%(9/11),排除罪犯冠状动脉病变的特异度为83%(162/195)。
- CNR在冠状动脉节段内以血池信号为参照进行量化,罪犯病变节段与无罪犯病变节段的CNR分别为6.1(3.9–16.5)和2.1(0.5–3.5),p<0.001。
- 薄纤维帽粥样斑块节段与无斑块或早期动脉粥样硬化病变节段的CNR分别为9.2(3.3–13.7)和2.1(0.5–3.4),p=0.001。
临床应用与阅片要点
- 阅片时可将钆磷维塞三钠给药约24小时后的GE-CMR冠状动脉节段信号增强(以血池信号为参照的CNR)作为识别罪犯病变和薄纤维帽粥样斑块的影像线索。
- 判读时需注意,本研究中罪犯病变检出敏感度为82%(9/11)、特异度为83%(162/195),存在漏诊和误诊可能。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: This study sought to investigate the potential of the noninvasive albumin-binding probe gadofosveset-enhanced cardiac magnetic resonance (GE-CMR) for detection of coronary plaques that can cause acute coronary syndromes (ACS).
BACKGROUND: ACS are frequently caused by rupture or erosion of coronary plaques that initially do not cause hemodynamically significant stenosis and are therefore not detected by invasive x-ray coronary angiography (XCA).
METHODS: A total of 25 patients with ACS or symptoms of stable coronary artery disease underwent GE-CMR, clinically indicated XCA, and optical coherence tomography (OCT) within 24 h. GE-CMR was performed approximately 24 h following a 1-time application of gadofosveset-trisodium. Contrast-to-noise ratio (CNR) was quantified within coronary segments in comparison with blood signal.
RESULTS: A total of 207 coronary segments were analyzed on GE-CMR. Segments containing a culprit lesion in ACS patients (n = 11) showed significant higher signal enhancement (CNR) following gadofosveset-trisodium application than segments without culprit lesions (n = 196; 6.1 [3.9 to 16.5] vs. 2.1 [0.5 to 3.5]; p < 0.001). GE-CMR was able to correctly identify culprit coronary lesions in 9 of 11 segments (sensitivity 82%) and correctly excluded culprit coronary lesions in 162 of 195 segments (specificity 83%). Additionally, segmented areas of thin-cap fibroatheroma (n = 22) as seen on OCT demonstrated significantly higher CNR than segments without coronary plaque or segments containing early atherosclerotic lesions (n = 185; 9.2 [3.3 to 13.7] vs. 2.1 [0.5 to 3.4]; p = 0.001).
CONCLUSIONS: In this study, we demonstrated for the first time the noninvasive detection of culprit coronary lesions and thin-cap fibroatheroma of the coronary arteries in vivo by using GE-CMR. This method may represent a novel approach for noninvasive cardiovascular risk prediction.
引用
- Engel LC, Landmesser U, Gigengack K, et al. Novel Approach for In Vivo Detection of Vulnerable Coronary Plaques Using Molecular 3-T CMR Imaging With an Albumin-Binding Probe. JACC Cardiovasc Imaging. 2018. PMID: 29361487. doi:10.1016/j.jcmg.2017.10.026
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。